After todays confirmation of the passing of the PACT act, that specifically and explicitly includes "non-invasive FDA approved screening technologies" in the language and directly support the VA, with whom Philips and 4DX are working with, this FA news should drive price to cover the gap (yellow box). Next stages are a formal signing with the VA and Philips and then revenues will start flowing. With an expected ramp up in 4DX general business too, this is looing like a hot stock for 2024. IMO.
